Form 4: Fortress Biotech CFO David Jin Acquires 5,000 Shares Through Employee Stock Purchase Plan

David Jin, CFO of Fortress Biotech, reports the acquisition of 5,000 shares of common stock through the company's Employee Stock Purchase Plan at a price of $1.2155 per share.

Summary

• David Jin, the Chief Financial Officer of Fortress Biotech, acquired 5,000 shares of the company's common stock on April 1, 2025.
• The shares were purchased through the Employee Stock Purchase Plan at a price of $1.2155 per share.
• Following the transaction, Jin directly owns 1,245,893 shares of Fortress Biotech, which includes 1,230,000 shares underlying deferred restricted stock units.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a routine transaction related to an employee stock purchase plan. It doesn't necessarily indicate a strong positive or negative outlook, but rather a standard course of business.

Positives

• The CFO's participation in the Employee Stock Purchase Plan could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Monitoring insider activity can provide insights into management's sentiment about the company's prospects.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired by an executive.

Key Dates

Keywords

Fortress Biotech, FBIO, David Jin, CFO, Employee Stock Purchase Plan, Share Acquisition, Form 4, Beneficial Ownership